Ichiro Nakashima Selected Research

Proteins (Proteins, Gene)

12/2022	Diagnosis and classification of optic neuritis.
6/2018	CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
1/2018	Abnormal Osmolality Gap Exists in Distal Symmetric Polyneuropathy.
3/2017	MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.
11/2016	Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.
10/2016	Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
1/2015	Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
8/2007	Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
7/2007	Candidate antigens specifically detected by cerebrospinal fluid-IgG in oligoclonal IgG bands-positive multiple sclerosis patients.
1/2005	Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ichiro Nakashima Research Topics

Disease

69	Neuromyelitis Optica (Devic's Disease) 02/2024 - 04/2004
41	Multiple Sclerosis 03/2024 - 11/2002
28	Optic Neuritis (Retrobulbar Neuritis) 12/2022 - 01/2011
21	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 08/2007
11	Myelitis 12/2021 - 01/2011
9	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2017
6	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 03/2021 - 10/2015
5	Infections 01/2021 - 10/2017
5	Leukocytosis (Pleocytosis) 01/2020 - 05/2012
4	Vision Disorders (Hemeralopia) 01/2022 - 06/2018
4	Headache (Headaches) 05/2021 - 01/2019
4	Central Nervous System Diseases (CNS Diseases) 11/2018 - 11/2014
4	Neoplasms (Cancer) 06/2018 - 04/2008
3	Ganglion Cysts (Ganglion) 01/2022 - 01/2017
3	Encephalomyelitis (Myeloencephalitis) 01/2020 - 08/2016
3	Disease Progression 07/2018 - 10/2015
3	Nervous System Diseases (Neurological Disorders) 01/2018 - 04/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 05/2003
3	Disorders of Excessive Somnolence (Hypersomnia) 12/2012 - 07/2009
2	Aseptic Meningitis 09/2023 - 08/2014
2	Meningococcal Infections 01/2023 - 01/2017
2	Atrophy 01/2022 - 12/2017
2	Cognitive Dysfunction 06/2021 - 10/2017
2	Pain (Aches) 06/2021 - 09/2014
2	Epilepsy (Aura) 06/2021 - 11/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2019
2	Fatigue 01/2021 - 06/2015
2	Myasthenia Gravis 10/2020 - 11/2013
2	Hemorrhage 01/2020 - 01/2020
2	Meningitis 11/2019 - 10/2008
2	Progressive Multifocal Leukoencephalopathy 01/2018 - 01/2017
2	Polyneuropathies (Polyneuropathy) 01/2018 - 11/2013
2	Paraproteinemias (Monoclonal Gammopathy) 10/2016 - 01/2015
2	POEMS Syndrome (Syndrome, POEMS) 10/2016 - 01/2015
2	Hiccup (Hiccups) 01/2016 - 06/2013
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2015 - 10/2004
2	Meningoencephalitis 08/2014 - 12/2012
2	Inflammation (Inflammations) 02/2014 - 05/2012
2	Necrosis 06/2013 - 10/2004
2	Opticospinal Multiple Sclerosis 01/2011 - 02/2009
1	Body Weight (Weight, Body) 01/2024
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2023
1	Inappropriate ADH Syndrome (SIADH) 01/2023
1	Sclerosis 01/2023
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2023
1	Thrombosis (Thrombus) 07/2022
1	Nasopharyngitis 05/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2021

Drug/Important Bio-Agent (IBA)

31	Myelin-Oligodendrocyte GlycoproteinIBA 09/2023 - 02/2014
28	AntibodiesIBA 07/2023 - 02/2009
26	Immunoglobulin G (IgG)IBA 03/2022 - 12/2004
16	AutoantibodiesIBA 01/2023 - 12/2004
12	Aquaporin 4IBA 01/2021 - 02/2009
10	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2005
9	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2010
8	SteroidsIBA 05/2023 - 10/2014
8	eculizumab FDA Link 01/2023 - 01/2017
8	Retinaldehyde (Retinal)IBA 12/2022 - 01/2016
8	Rituximab (Mabthera)FDA Link 04/2022 - 07/2011
6	Complement System Proteins (Complement)IBA 01/2024 - 01/2013
5	CytokinesIBA 01/2021 - 10/2004
5	Oligoclonal BandsIBA 01/2018 - 06/2004
5	ChemokinesIBA 11/2016 - 04/2004
4	Monoclonal AntibodiesIBA 02/2024 - 11/2013
4	Aquaporins (Water Channels)IBA 05/2021 - 05/2007
4	Methylprednisolone FDA LinkGeneric 07/2020 - 04/2012
4	AntigensIBA 08/2016 - 05/2007
4	InterferonsIBA 10/2012 - 10/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2014
3	anti-aquaporin 4 autoantibodyIBA 12/2017 - 03/2009
3	OrexinsIBA 12/2012 - 07/2009
2	Complement C5 (Complement 5)IBA 01/2024 - 01/2023
2	ravulizumabIBA 01/2024 - 01/2023
2	ElectrolytesIBA 01/2023 - 01/2018
2	Complement Inactivating AgentsIBA 01/2023 - 05/2021
2	VaccinesIBA 07/2022 - 12/2021
2	Prednisolone (Predate)FDA LinkGeneric 04/2021 - 01/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2019
2	Glial Fibrillary Acidic ProteinIBA 01/2020 - 08/2014
2	EnzymesIBA 01/2020 - 08/2007
2	Myelin Basic ProteinIBA 01/2020 - 03/2017
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 03/2014
2	ChloridesIBA 01/2018 - 01/2018
2	AlbuminsIBA 01/2018 - 05/2012
2	Natalizumab (Tysabri)FDA Link 01/2017 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2015
2	Thalidomide (Thalomid)FDA Link 10/2016 - 01/2015
2	Therapeutic UsesIBA 01/2011 - 02/2005
2	Codon (Codons)IBA 04/2008 - 11/2007
1	satralizumabIBA 02/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2023
1	Vasopressins (Vasopressin)IBA 01/2023
1	ofatumumab FDA Link 01/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2022
1	BNT162 VaccineIBA 12/2021
1	COVID-19 VaccinesIBA 12/2021

Therapy/Procedure

15	Therapeutics 03/2024 - 10/2004
3	Plasma Exchange 05/2023 - 05/2007
3	Secondary Prevention 01/2023 - 01/2021
2	Aftercare (After-Treatment) 12/2012 - 04/2012